Compound heterozygosity for two GHR missense mutations in a patient affected by Laron Syndrome: a case report

Abstract Background Mutations localized in the Growth Hormone Receptor (GHR) gene are often associated with the pathogenesis of Laron Syndrome, an autosomal recessive hereditary disorder characterized by severe growth retardation. Biochemically, patients present normal to high circulating GH levels,...

Full description

Saved in:
Bibliographic Details
Main Authors: Stefania Moia (Author), Daniele Tessaris (Author), Silvia Einaudi (Author), Luisa de Sanctis (Author), Gianni Bona (Author), Simonetta Bellone (Author), Flavia Prodam (Author)
Format: Book
Published: BMC, 2017-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_a22ef0f817ec4cdf99517fdf66c8817f
042 |a dc 
100 1 0 |a Stefania Moia  |e author 
700 1 0 |a Daniele Tessaris  |e author 
700 1 0 |a Silvia Einaudi  |e author 
700 1 0 |a Luisa de Sanctis  |e author 
700 1 0 |a Gianni Bona  |e author 
700 1 0 |a Simonetta Bellone  |e author 
700 1 0 |a Flavia Prodam  |e author 
245 0 0 |a Compound heterozygosity for two GHR missense mutations in a patient affected by Laron Syndrome: a case report 
260 |b BMC,   |c 2017-10-01T00:00:00Z. 
500 |a 10.1186/s13052-017-0411-7 
500 |a 1824-7288 
520 |a Abstract Background Mutations localized in the Growth Hormone Receptor (GHR) gene are often associated with the pathogenesis of Laron Syndrome, an autosomal recessive hereditary disorder characterized by severe growth retardation. Biochemically, patients present normal to high circulating GH levels, in presence of very low or undetectable IGF-I levels, which do not rise after rhGH treatment. Case presentation We describe the case of a 3.8 years old girl with symmetrical short stature (−3.76 SDS), low IGF-1 and IGFBP-3, in presence of normal GH levels. Parents were not relatives and there was no family history of short stature. During the second day of birth, she developed severe hypoglycaemia that required glucose infusion. She presented frontal bossing and depressed nasal bridge. IGF-1 generation test showed no response, suggesting a GH resistance evidence. In the hypothesis of Laron Syndrome, we decided to perform a molecular analysis of Growth Hormone Receptor (GHR) gene. This analysis demonstrated that the patient was compound heterozygote for two missense mutations. Conclusions GHR gene mutations are a well demonstrated cause of GH insensitivity. In heterozygous patients, probably the normal stature may be achieved by a compensatory mechanism of GH secretion or signalling. On the contrary, in homozygous or compound heterozygous patients these compensatory mechanisms are inadequate, and short stature may be the consequence. 
546 |a EN 
690 |a Growth Hormone 
690 |a Growth Hormone Receptor 
690 |a Laron Syndrome 
690 |a Short Stature 
690 |a Pediatrics 
690 |a RJ1-570 
655 7 |a article  |2 local 
786 0 |n Italian Journal of Pediatrics, Vol 43, Iss 1, Pp 1-4 (2017) 
787 0 |n http://link.springer.com/article/10.1186/s13052-017-0411-7 
787 0 |n https://doaj.org/toc/1824-7288 
856 4 1 |u https://doaj.org/article/a22ef0f817ec4cdf99517fdf66c8817f  |z Connect to this object online.